Company / Gross Margin
Avanos Medical, Inc. Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
50.5%
FY2025
5-year range
50.5% / 57.6%
FY2021-FY2025
Trend
-9.0%
vs FY2024
Sector context
#60 of 91
Health Care
What the data says
At 50.5%, Avanos Medical, Inc.'s gross margin ranks #60 of 91 in the Health Care sector. Gross Margin has declined for 3 consecutive years, from 57.6% in FY2022 to 50.5% in FY2025.
Based on SEC 10-K filings.
50.5% in FY2025 with a 5-year CAGR of -1.4%.
Declined from 56.4% to 50.5% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -7.2pp
- 5-Year Change
- -1.4pp
- 10-Year Change
- -
Sector benchmark
#60 of 91 in Health CareTop 66% of 91This company 50.5% Sector average 53.8%
▼
-6.2% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s gross margin has declined for 3 consecutive years.
- In FY2025, gross margin decreased 9.0% year-over-year.
- Currently 3.3pp below the Health Care sector average.
- Peak gross margin was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 50.5% | -9.0% |
| FY2024 | 55.4% | -1.7% |
| FY2023 | 56.4% | -2.1% |
| FY2022 | 57.6% | +13.0% |
| FY2021 | 51.0% | -1.8% |
| FY2020 | 51.9% | -10.0% |
| FY2019 | 57.6% | -3.8% |
| FY2018 | 59.9% | +8.8% |
| FY2017 | 55.1% | +5.0% |
| FY2016 | 52.5% | +3.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026